Copd Case Study

I will analyse the prevalence of the condition and what the potential causes may be. My interests have been directed to pre hospital care and community lead treatment packages, which are potentially available to the patient, as this is the acute environment, which I will have contact with in my employment as a paramedic. The initial reading was to understand COPD as a chronic condition, what is COPD? and its prevalence in the population. The (World health organisation, 2000), states that one in four deaths in the world are caused by COPD. In 2010 (Vos T Flaxman etal, 2012), says globally there were approximately 329 million, which is 4.8% of the population who are affected by this chronic condition, In the UK (NICE, 2010), have estimated that 3 million people suffer from COPD, with more yet to be diagnosed. This information about the amount of people living with this condition was surprising, as I little knowledge of its existence. During the early 1960’s (Timothy Q. Howes, 2005), says the term COPD had been designated as a single term unifying all the chronic respiratory diseases. Since then the term COPD, has been sub divided in to three umbrella areas, Bronchitis, Emphysema and Chronic asthma, which are separate conditions, which I have been previously aware of as their individual conditions. The 58 year old patient who we visited,

R.W. appears with progressive difficulty getting his breath while doing simple tasks, and also having difficulty doing any manual work, complains of a cough, fatigue, and weight loss, and has been treated for three respiratory infections a year for the past 3 years. On physical examination, CNP notice clubbing of his fingers, use accessory muscles for respiration, wheezing in the lungs, and hyperresonance on percussion of the lungs, and also pulmonary function studies show an FEV1 of 58%. These all symptoms and history represented here most strongly indicate the probability of chronic obstructive pulmonary disease (COPD). COPD is a respiratory disease categorized by chronic airway inflammation, a decrease in lung function over time, and gradual damage in quality of life (Booker, 2014).

The study began with 32 patients having stages II to IV COPD. They had to meet the criteria pertaining to the Global Initiative for Chronic Obstructive Pulmonary Disease; total lung capacity >120%, (FEV1/FVC) <70%, FEV1 <80%, RV/TLC >140% and >40% of predicted values in stable conditions. Patients were removed from the study if they had asthma, heart failure, orthopedic impairments of the shoulder girdle, recent surgery, past thoracic fractures, pneumothorax, and claustrophobia.

The study included 100 patients with COPD. All patients fulfilled the inclusion and exclusion criteria. According to its demographic and clinical parameters and treatment groups differ among themselves. Completed the study, all patients included in the study. The therapy in all patients with a clinically meaningful improvement of symptoms was observed.

COPD is an important disease to be informed about because it affects millions of people. This paper discusses signs and symptoms, treatments, abnormalities you may find, as well as many of interesting things about COPD. Being informed about COPD can also possibly decrease your chances of developing the disease.

Description: Caused by obstructed airflow within the lungs, Chronic Obstructive Pulmonary Disease (COPD) also causes chronic inflamed lungs.

Health status (HS) was evaluated only in COPD patients with the disease-specific Clinical COPD Questionnaire (CCQ). This has a 10 items and three domain scores for symptoms (CCQ-S), mental status (CCQ-M)and functional status (CCQ-F), and it also has a total score (CCQ-T) [14]. Higher scores are associated with worse health

51 patients (46.8%) were assigned to the case cohort and 58 patients (53.2%) were assigned to the control cohort. The difference in the rate of 30-day readmission between cases (21.6%) and controls (13.8%) was not statistically significant (P = 0.3203). The overall rate of 30-day readmission in the study population was 17.4%. The mean hospital length of stay was similar between both groups. A history of COPD exacerbation in the preceding 12 months was the only significant predictor of 30-day readmission (P = 0.0114). The mean PIF (50.4 ± 19.35 L/min, n = 49) was similar between the patients with a 30-day readmission and those without (P = 0.7608). There was a significant negative correlation between PIF and patient’s age (r = -0.378; P =

Chronic Obstructive Pulmonary disease (COPD) is the third leading cause of death in the United States. “COPD affects over 24 million Americans and our community stretches across all 50 states.” (COPD Foundation, 2016, p. 1). In this paper we will go over the main causes of COPD, what is emphysema and chronic bronchitis, the symptoms, also we will cover the different stages COPD and some of the common treatments. Although COPD does not discriminate by age it is primarily found to affect the middle age and older group. As we go further

Although not curable, chronic obstructive pulmonary disease (COPD) is a familiar, treatable, but avoidable disease that is still a huge health problem in the United States. According to the Global Initiative for Chronic Obstructive Lung Disease, “COPD is the fourth leading cause of chronic morbidity and mortality in the United States and is projected to rank fifth in 2020 as a worldwide problem according to a study published by the World Bank/World Health Organization.”1 Mortality from COPD is also expected to increase despite medical advances in the treatment of the disease.

This essay will analyse and evaluate a health resource designed for individuals newly diagnosed with Chronic Obstructive Pulmonary Disease (COPD). It appears that it is difficult to estimate the prevalence of COPD due to misdiagnosis (Carrier, 2009) and under-diagnosis (HSE, 2014). The Healthcare Commission (2006) estimates that 3 million people in the UK have COPD and that approximately 2 million of them are undiagnosed. The World Health Organization (WHO) estimates that more than 65 million people have COPD and that the death rate is projected to increase by more than 30% in the next ten years.

Chronic Obstructive Pulmonary Disease, also known as COPD, is the third leading cause of death in the United States. COPD includes extensive lungs diseases such as emphysema, non-reversible asthma, specific forms of bronchiectasis, and chronic bronchitis. This disease restricts the flow of air in and out of the lungs. Ways in which these limitations may occur include the loss of elasticity in the air sacs and throughout the airways, the destruction of the walls between air sacs, the inflammation or thickening of airway walls, or the overproduction of mucus in airways which can lead to blockage. Throughout this paper I am going to explain the main causes, symptoms, diagnosis, and ways to reduce COPD.

Chronic obstructive pulmonary disease (COPD) is a lung disease which can be characterized by chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible. COPD can be a life threatening underlying diagnosis. A COPD diagnosis can be confirmed by a simple test called spirometry. This test would show how deeply a person can breathe and how fast air can move into and out of the lungs. At the initial stage, COPD may not cause any symptoms or show only mild signs. As the disease worsens symptoms such as, shortness of breath, wheezing, chest tightness and persistent cough with phlegm that never seems to go away. The risk factors of COPD include:

The AECOPD are the leading cause of medical consultation and hospitalization in patients with COPD, also determining degradation of quality of life and aggravation the anatomical and functional damage and respiratory [75,2,3,76] placing it is self directly or indirectly as a frequent cause of mortality [77-78], which can

In 2002, Chronic Obstructive Pulmonary Disease (COPD) was identified as the 5th leading cause of death worldwide, and it is forecast to become the 3rd leading cause of death by 2030 (WHO, 2016). COPD is an umbrella term used to describe a group of irreversible but treatable lung diseases including emphysema and chronic bronchitis. The disease, which primarily affects the respiratory system, is characterised by chronic and progressive airflow limitation due to inflammation of the airways and lungs caused by inhalation of harmful particles or gasses. Characteristic symptoms of COPD include increased breathlessness, cough, and sputum production.